Anticoagulation for portal vein thrombosis in cirrhosis.
作者信息
Qi Xingshun, Han Guohong, Wu Kaichun, Fan Daiming
出版信息
Am J Med. 2010 Sep;123(9):e19-20; author reply e21. doi: 10.1016/j.amjmed.2010.03.019.
PMID:20800136
Abstract
摘要
相似文献
1
Anticoagulation for portal vein thrombosis in cirrhosis.
Am J Med. 2010 Sep;123(9):e19-20; author reply e21. doi: 10.1016/j.amjmed.2010.03.019.
2
Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
J Clin Gastroenterol. 2010 Jul;44(6):448-51. doi: 10.1097/MCG.0b013e3181b3ab44.
3
Successful management of acute portal vein thrombosis by low molecular weight heparin and oral anticoagulation.
Am J Gastroenterol. 2002 Jun;97(6):1567-8. doi: 10.1111/j.1572-0241.2002.05750.x.
4
Low molecular weight heparin in management and prevention of portal vein thrombosis.
Thromb Res. 2014 Oct;134(4):761-2. doi: 10.1016/j.thromres.2014.08.003. Epub 2014 Aug 16.
5
Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH.
J Thromb Haemost. 2024 Sep;22(9):2653-2669. doi: 10.1016/j.jtha.2024.05.023. Epub 2024 May 31.
6
Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
Ann Surg. 2010 Jan;251(1):76-83. doi: 10.1097/SLA.0b013e3181bdf8ad.
7
Scuba diving and portal vein thrombosis: a case report.
Clin J Sport Med. 2010 Nov;20(6):497-9. doi: 10.1097/JSM.0b013e3181fab19d.
8
Risk stratification in the management of portal vein thrombosis in cirrhosis.
J Gastrointestin Liver Dis. 2016 Mar;25(1):119-20. doi: 10.15403/jgld.2014.1121.251.qix.
9
[Extrahepatic portal vein thrombosis following laparoscopic cholecystectomy].
Chirurg. 2003 Mar;74(3):244-7. doi: 10.1007/s00104-002-0588-0.
10
Portal vein thrombosis: an unexpected finding in a 28-year-old male with abdominal pain.
J Am Board Fam Med. 2008 May-Jun;21(3):237-43. doi: 10.3122/jabfm.2008.03.070157.
引用本文的文献
1
Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients.
Medicine (Baltimore). 2017 Oct;96(42):e8256. doi: 10.1097/MD.0000000000008256.
2
Comparison of two laparoscopic splenectomy plus pericardial devascularization techniques for management of portal hypertension and hypersplenism.
Surg Endosc. 2015 Dec;29(12):3819-26. doi: 10.1007/s00464-015-4147-4. Epub 2015 Mar 18.
3
Spontaneous resolution of portal vein thrombosis in cirrhosis: where do we stand, and where will we go?
Saudi J Gastroenterol. 2014 Sep-Oct;20(5):265-6. doi: 10.4103/1319-3767.141680.
4
Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study.
World J Gastroenterol. 2013 Nov 14;19(42):7447-54. doi: 10.3748/wjg.v19.i42.7447.
5
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial.
BMJ Open. 2013 Jul 11;3(7). doi: 10.1136/bmjopen-2013-003370. Print 2013.
6
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.
Med Sci Monit. 2012 Aug;18(8):HY37-41. doi: 10.12659/msm.883252.
Zotero 插件